entertainment -WSS

entertainment

author：comprehensive 2025-10-02 23:47:30 - browse：12

MODERNA - Norwood facility — Alex Hogan/STAT

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.

The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.

“We’re excited to move forward in our discussions with regulators, and hopefully continue to help address respiratory viruses globally,” Moderna President Stephen Hoge told STAT in an interview in which he acknowledged that the fall 2025 vaccine rollout is a target the company would like to hit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Experts study whether long Covid risk adds up with each reinfection

hotspot

WSS

Biotech stock slump in 2023: awaiting the turnaround

Plane’s emergency slide plummets from sky, hits Chicago home

'Reaching a detente': STAT's Helen Branswell on covering Covid

How Vertex's cystic fibrosis drug is changing patients' lives

Emergency workers more likely to restrain Black patients: study

Norman Reedus' Daryl Dixon

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Alkermes shareholders re

The kidney, in all its complexity, is captured in a new atlas

Malaria cases in Florida and Texas: Here’s what you need to know

How AI helped researchers track recovery from depression

Jerome Adams on the need for new antivirals for Covid

Intarcia’s device

Medical records are filled with copy

STAT Virtual Event: Putting AI to the Test

ChatGPT in medicine: STAT answers readers' burning questions

Celebrate National Dole Whip Day for 3 days this week at Disney

hotspot

How Vertex's cystic fibrosis drug is changing patients' lives

How AI helped researchers track recovery from depression

What Congress can do to address the rural doctor shortage

It's been 20 years since Dolly the sheep. Where's my clone?

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Stanford updates investigation of president’s past research

hotspot

knowledge

hotspot

leisure time